Clinical Trials
38 trialsMAST
University Health Network, Toronto
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
HTA Co., Ltd.
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Alliance for Clinical Trials in Oncology
Transamin
Instituto do Cancer do Estado de São Paulo
ESTO2
Tampere University Hospital
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
Göteborg University
AdRad
Scandinavian Prostate Cancer Group
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
M.D. Anderson Cancer Center
PATCH
University College, London
RaRe
Amsterdam UMC, location VUmc
MAPOCD
RenJi Hospital
TEPGALCHOL
Central Hospital, Nancy, France
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
Tianjin Medical University Second Hospital
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Brooke Army Medical Center
IG-VMAT for Localized Prostate Cancer
Beijing Hospital
ASIST
Canadian Urology Research Consortium
Prospective RCT on Post Prostatectomy Urine Leak
Institut Mutualiste Montsouris
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
SensiCab
Örebro University, Sweden
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer
Helsinki University Central Hospital
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
University of British Columbia
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
National Cancer Institute (NCI)
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence
Copenhagen University Hospital at Herlev
Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer
Maria Sklodowska-Curie National Research Institute of Oncology
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
University of British Columbia
Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer
National Taiwan University Hospital
PROPENLAP
Assistance Publique - Hôpitaux de Paris
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
National Cancer Institute (NCI)
BIOPRES
Amphia Hospital
Osteoporosis
Odense University Hospital
Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
I-125 Versus Pd-103 for Low Risk Prostate Cancer
VA Puget Sound Health Care System
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
VA Puget Sound Health Care System
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
New York Prostate Institute